Sarepta Therapeutics Inc
XMUN:AB3A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sarepta Therapeutics Inc
XMUN:AB3A
|
US |
|
Gold Road Resources Ltd
ASX:GOR
|
AU |
|
M
|
Moonlight Resources Ltd
ASX:ML8
|
AU |
|
Fresenius SE & Co KGaA
MIL:FRE
|
DE |
|
C
|
Citigroup Inc
SWB:TRVC
|
US |
|
C
|
China Pacific Insurance Group Co Ltd
F:75C
|
CN |
Shareholder Yield
Current shareholder yield for 
AB3A is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
AB3A Price
Sarepta Therapeutics Inc
| Average Annual Return | 22.54% |
| Standard Deviation of Annual Returns | 35.67% |
| Max Drawdown | -93% |
| Market Capitalization | 2.3B EUR |
| Shares Outstanding | 62 096 878 |
| Percentage of Shares Shorted |
N/A
|
AB3A Return Decomposition
Main factors of price return
Stock Splits
AB3A's latest stock split occurred on Jul 12, 2012
The company executed a 1-for-6 stock split, meaning that for every 6 shares held, investors received 1 new share.
The adjusted shares began trading on Jul 12, 2012. This was the only stock split in AB3A's history.
